JIKUZONO Tatsuya | Shin Nippon Biomedical Laboratories (SNBL), Ltd
スポンサーリンク
概要
関連著者
-
Kito Go
新日本科学
-
Kito Go
Shin Nippon Biomedical Laboratories (snbl) Ltd
-
JIKUZONO Tatsuya
Shin Nippon Biomedical Laboratories (SNBL), Ltd
-
Hamada Taiji
Shin Nippon Biomedical Laboratories (snbl) Ltd
-
Jikuzono Tatsuya
Shin Nippon Biomedical Laboratories (snbl) Ltd
-
KITO Go
Shin Nippon Biomedical Laboratories (SNBL), Ltd.
-
HASHIMOTO Keitaro
Department of Pharmacology, Interdisciplinary Graduate School of Medicine and Engineering, Universit
-
Nagata Ryoichi
Shin Nippon Biomedical Laboratories (snbl) Ltd.
-
Nagata Ryoichi
Shin Nippon Biomedical Laboratories Ltd.
-
Kamenosono Takeshi
Shin Nippon Biomedical Laboratories, Ltd., Drug Safety Research Laboratories
-
Kamenosono Takeshi
Shin Nippon Biomedical Laboratories Ltd. Drug Safety Research Laboratories
-
HORII Ikuo
Nippon Roche Research Center
-
HAMADA Taiji
Shin Nippon Biomedical Laboratories (SNBL), Ltd
-
KOBAYASHI Kazuko
Nippon Roche Research Center
-
Hamada Taiji
Shin Nippon Biomedical Laboratories Ltd.
-
Nagata Ryoichi
Toxicology Division Shin Nippon Biomedical Laboratories
-
Hashimoto Keitaro
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Nagayama Shinichi
Shin Nippon Biomedica Laboratories, Ltd.
-
FURUKAWA Takeshi
Shin Nippon Biomedical Laboratories, Ltd.
-
Hashimoto Keitaro
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Hashimoto Keitaro
Department Of Pharmacology Interdisciplinary Graduate School Of Medicine And Engineering University
-
Horii Ikuo
Nippon Roche K. K. Research Center
-
Nagayama Shinichi
Shin Nippon Biomedical Laboratories Ltd.
-
Furukawa Takeshi
Shin Nippon Biomedical Laboratories Ltd.
-
Nagata Ryoichi
Shin Nippon Biomedical Lab. Ltd.
-
HASHIMOTO Keitaro
Department of Phamacology, Yamanashi Medical University
著作論文
- DEVELOPMENT OF TELEMETRY SYSTEM IN THE COMMON MARMOSET : CARDIOVASCULAR EFFECTS OF ASTEMIZOLE AND NICARDIPINE
- O-39 Strategy for preclinical evaluation of the proarrhythmic risk.(Proceedings of the 27th Annual Meeting)